Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR and crRNAs02:53

CRISPR and crRNAs

17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

17
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
17
CRISPR01:59

CRISPR

51.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
51.9K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

30
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
30
Homologous Recombination02:31

Homologous Recombination

50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K
Caspases01:24

Caspases

12.5K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
12.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CARF-HAD phosphatase effectors provide immunity during the type III-A CRISPR-Cas response.

Nucleic acids research·2025
Same author

CRISPR-Cas-associated SCCmec Variants in Methicillin-resistant Staphylococcus aureus Evade Rapid Diagnostic Detection.

The Journal of infectious diseases·2025
Same author

Sharing Failure as a Graduate Student.

Chembiochem : a European journal of chemical biology·2023
Same author

Mechanistic Origin of Favorable Substituent Effects in Excellent Cu Cyclam Based HNO Sensors.

Angewandte Chemie (International ed. in English)·2022
Same author

Principles and practice for SARS-CoV-2 decontamination of N95 masks with UV-C.

Biophysical journal·2021
Same author

Major Insights into Microbiology: An Interview with Luciano Marraffini.

The CRISPR journal·2020
Same journal

Drugging the proteome via large-scale chemoproteomics.

Trends in biochemical sciences·2026
Same journal

Peptideins: Navigating the gray zone of the proteome.

Trends in biochemical sciences·2026
Same journal

A metabolon channels nicotine biosynthesis.

Trends in biochemical sciences·2026
Same journal

Better call chaperone.

Trends in biochemical sciences·2026
Same journal

Biochemistry at scale: Seeing both the forest and the trees.

Trends in biochemical sciences·2026
Same journal

Voices across Asia and Oceania: Biochemistry across borders.

Trends in biochemical sciences·2026
See all related articles

Related Experiment Video

Updated: Jul 11, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K

Type III CRISPR-Cas: beyond the Cas10 effector complex.

Gianna Stella1, Luciano Marraffini2

  • 1Laboratory of Bacteriology, The Rockefeller University, New York, NY 10065, USA; Tri-Institutional PhD Program in Chemical Biology, Weill Cornell Medical College, Rockefeller University and Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Trends in Biochemical Sciences
|November 10, 2023
PubMed
Summary
This summary is machine-generated.

This review explores how prokaryotic immune systems, specifically Type III CRISPR-Cas, defend against viral invaders. Beyond the main Cas10 protein, researchers examine how secondary molecules and enzymes regulate immune responses to ensure effective protection against bacteriophages and plasmids.

Keywords:
CARF-domain effectorsCRISPR immunityCas7-11ancillary nucleasescyclic oligoadenylates (cOA)ring nucleasesBacteriophage defenseCARF-domain effectorsCraspase complexCyclic oligoadenylatesRing nucleases

Frequently Asked Questions

More Related Videos

Substrate Generation for Endonucleases of CRISPR/Cas Systems
11:53

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

27.4K
CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art
10:18

CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art

Published on: May 28, 2019

17.1K

Related Experiment Videos

Last Updated: Jul 11, 2025

Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

21.8K
Substrate Generation for Endonucleases of CRISPR/Cas Systems
11:53

Substrate Generation for Endonucleases of CRISPR/Cas Systems

Published on: September 8, 2012

27.4K
CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art
10:18

CRISPR/Cas12a Multiplex Genome Editing of Saccharomyces cerevisiae and the Creation of Yeast Pixel Art

Published on: May 28, 2019

17.1K

Area of Science:

  • Microbiology and molecular genetics of Type III CRISPR-Cas systems
  • Prokaryotic immunology and host-pathogen interactions

Background:

Prokaryotic organisms face constant threats from viral invaders like bacteriophages and plasmids. These microbes developed sophisticated immune mechanisms to survive such environmental pressures. Type III CRISPR-Cas loci represent a highly prevalent class of these adaptive defense systems. While the Cas10 effector complex serves as a primary recognition unit, its full functional scope remains under active investigation. Prior research has shown that this complex coordinates multiple enzymatic activities upon identifying foreign genetic material. However, the broader regulatory network surrounding these systems is not fully understood. That uncertainty drove interest in identifying auxiliary components that modulate immune signaling. No prior work had resolved the complete interplay between these secondary effectors and the primary complex.

Purpose Of The Study:

The aim of this review is to examine the functional landscape of prokaryotic immune systems beyond the canonical effector. Researchers seek to understand how these systems achieve high levels of complexity. The study addresses the specific problem of how secondary components modulate immune signaling. This motivation stems from the need to map the full range of defense activities. The authors investigate how ancillary nucleases contribute to the overall immune response. They also explore the regulatory mechanisms governing cyclic oligoadenylate production. Furthermore, the work clarifies the role of CRISPR-associated proteases in responding to phage infection. This review provides a synthesis of current knowledge to guide future investigations into these intricate molecular networks.

Main Methods:

The review approach involves a systematic synthesis of recent literature regarding prokaryotic defense mechanisms. Authors examine data concerning the functional diversity of immune components beyond the canonical complex. They evaluate experimental findings related to ancillary nucleases and their sensing capabilities. The study methodology includes analyzing the regulatory roles of ring nucleases in signaling pathways. Researchers also investigate the biochemical properties of CRISPR-associated proteases. This review approach integrates structural and functional studies to map the immune network. The authors compare different experimental models to identify common regulatory themes. They synthesize evidence from diverse studies to provide a comprehensive overview of these complex systems.

Main Results:

Key findings from the literature indicate that immune systems utilize cyclic oligoadenylates as second messengers. These molecules activate CARF-domain effectors to initiate a robust defense response. The literature shows that ancillary nucleases provide protection by sensing these signaling molecules. Studies reveal that ring nucleases play a role in regulating the production of cyclic oligoadenylates. Research demonstrates that CRISPR-associated proteases facilitate a transcriptional response during viral infection. The findings highlight the Craspase complex as a significant mediator of this response. Data suggest that these systems coordinate multiple enzymatic activities to neutralize invaders. The literature confirms that immune defense extends beyond the activity of the primary Cas10 complex.

Conclusions:

The authors synthesize evidence regarding the diverse regulatory landscape of prokaryotic immunity. They highlight how ancillary nucleases provide defense by detecting specific signaling molecules. This review clarifies the role of ring nucleases in controlling the duration of immune activation. The researchers propose that CRISPR-associated proteases facilitate a sophisticated transcriptional response to infection. They emphasize that the Craspase complex functions as a key mediator in these pathways. The synthesis suggests that these systems operate through highly integrated multi-component networks. These findings imply that immune regulation extends far beyond the canonical effector complex. The review provides a comprehensive framework for understanding the complexity of these adaptive defense mechanisms.

The system utilizes a Cas10 complex that recognizes RNA guides. This recognition triggers single-stranded DNA degradation, synthesis of cyclic oligoadenylates, and target RNA cleavage. The researchers propose these activities work in concert to neutralize invading bacteriophages and plasmids.

Craspase is a CRISPR-associated protease. The authors describe its role in orchestrating a transcriptional response during phage infection. This component differs from ring nucleases, which primarily regulate the production of cyclic oligoadenylates.

Ancillary nucleases are necessary for defense because they sense cyclic oligoadenylates. This sensing mechanism allows the cell to respond to the presence of invaders. In contrast, ring nucleases act to limit the signaling cascade by degrading these molecules.

Cyclic oligoadenylates serve as second messengers. They activate CARF-domain effectors to initiate downstream immune responses. This signaling molecule is distinct from the RNA guides used for initial target recognition.

The researchers measure the activity of ring nucleases by their ability to degrade cyclic oligoadenylates. This phenomenon regulates the immune response duration. This measurement differs from assessing the cleavage of target RNA by the Cas10 complex.

The authors propose that the immune response is not limited to the Cas10 complex. They suggest that auxiliary proteins and proteases provide a layered defense. This perspective contrasts with earlier models that focused solely on the canonical effector.